Globe Life (GL) Q2 2025 earnings summary

Executive summary

• Net income for Q2 was $253 million ($3.05 per share), slightly down from $258 million a year ago, while net operating income per share rose 10% to $3.27.

• Net income for the six months ended June 30, 2025 was $507 million, with diluted EPS up 10% to $6.07 year-over-year.

• Total premium increased 5% year-over-year to $2.4 billion, with life premium up 3% and health premium up 8%.

• Book value per share excluding AOCI rose 10% year-over-year to $90.26.

• Agent count grew 6% sequentially, with strong recruiting and onboarding trends supporting future growth.

Financial highlights

• Net investment income was $282 million for Q2 and $563 million for the first half, both down 1% year-over-year; excess investment income declined 18% to $71 million for the half.

• Administrative expenses were $86 million for the quarter, up 5% year-over-year, representing 7.1% of premium.

• Share repurchases totaled $226 million (1.9 million shares) in Q2 and $403 million (3.3 million shares) in the first half of 2025.

• Fixed maturity portfolio yield was 5.29% in Q2, with invested assets totaling $21.5 billion.

• Insurance underwriting income rose 4% to $354.2 million for the quarter.

Outlook and guidance

• Life premium revenue expected to grow ~3.5% for the year; life underwriting margin as a percent of premium guided to 43%-45%.

• Health premium revenue expected to grow 8%-9%, with health underwriting margin at 25%-27%.

• Net operating earnings per diluted share for 2025 guided to $14.25-$14.65, representing 17% growth at midpoint; 10% growth excluding remeasurement gains.

• Share repurchases for 2025 expected to total $600-$650 million; dividends $80-$90 million.

• Management expects continued positive trends in sales and premium growth, with operating ROE in the mid-teens.